Upgrade to SI Premium - Free Trial

FDA approves Genentech's Enspryng for thyroid eye disease

October 16, 2026 1:00 AM
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), said the U.S. Food and Drug Administration has ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA